Skip to main content


Log in

Sociodemographic differences in utilization of fertility services among reproductive age women diagnosed with cancer in the USA

  • Fertility Preservation
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript



To determine whether sociodemographic differences exist among female patients accessing fertility services post-cancer diagnosis in a representative sample of the United States population.


All women ages 15–45 with a history of cancer who responded to the National Survey for Family Growth (NSFG) from 2011 to 2017 were included. The population was then stratified into 2 groups, defined as those who did and did not seek infertility services. The demographic characteristics of age, legal marital status, education, race, religion, insurance status, access to healthcare, and self-perceived health were compared between the two groups. The primary outcome measure was the utilization of fertility services. The complex sample analysis using the provided sample weights required by the NSFG survey design was used.


Five hundred forty-five women reported a history of cancer and were included in this study. Forty-three (7.89%) pursued fertility services after their cancer diagnosis. Using the NSFG sample weights, this equates to a population of 161,500.7 female cancer survivors in the USA who did utilize fertility services and 1,811,955.3 women who did not. Using multivariable analysis, household income, marital status, and race were significantly associated with women utilizing fertility services following a cancer diagnosis.


In this nationally representative cohort of reproductive age women diagnosed with cancer, there are marital, socioeconomic, and racial differences between those who utilized fertility services and those who did not. This difference did not appear to be due to insurance coverage, access to healthcare, or perceived health status.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others


  1. Cancer Treatment & Survivorship: Facts & Figures 2019–2021. In: American Cancer Society. 2019. Retrieved from:

  2. Pinelli S, Basile S. Fertility preservation: current and future perspectives for oncologic patients at risk for iatrogenic premature ovarian insufficiency. Biomed Res Int. 2018;2018:6465903.

    Article  Google Scholar 

  3. Klonoff-Cohen H, Chu E, Natarajan L, Sieber W. A prospective study of stress among women undergoing in vitro fertilization or gamete intrafallopian transfer. Fertil Steril. 2001;76:675–87.

    Article  CAS  Google Scholar 

  4. Domar AD, Broome A, Zuttermeister PC, Seibel M, Friedman R. The prevalence and predictability of depression in infertile women**Supported by grant 5R03MH45591 from the National Institute of Mental Health, Bethesda, Maryland.††Presented at the Annual Meeting of The American Fertility Society, Orlando, Florida, October 21 to 24, 1991. Fertility and Sterility 1992;58:1158–63.

  5. Bellieni C. The best age for pregnancy and undue pressures. J Family Reprod Health. 2016;10:104–7.

    PubMed  PubMed Central  Google Scholar 

  6. Gurgan T, Salman C, Demirol A. Pregnancy and assisted reproduction techniques in men and women after cancer treatment. Placenta. 2008;29:152–9.

    Article  Google Scholar 

  7. Selter J, Huang Y, Grossman Becht LC, Palmerola KL, Williams SZ, Forman E et al. Use of fertility preservation services in female reproductive-aged cancer patients. Am J Obstet Gynecol 2019;221:328.e1-.e16.

  8. Waimey KE, Smith BM, Confino R, Jeruss JS, Pavone ME. Understanding fertility in young female cancer patients. J Womens Health (Larchmt). 2015;24:812–8.

    Article  Google Scholar 

  9. Jones G, Hughes J, Mahmoodi N, Smith E, Skull J, Ledger W. What factors hinder the decision-making process for women with cancer and contemplating fertility preservation treatment? Hum Reprod Update. 2017;23:433–57.

    Article  Google Scholar 

  10. Barton SE, Missmer SA, Berry KF, Ginsburg ES. Female cancer survivors are low responders and have reduced success compared with other patients undergoing assisted reproductive technologies. Fertil Steril. 2012;97:381–6.

    Article  Google Scholar 

  11. Barton SE, Najita JS, Ginsburg ES, Leisenring WM, Stovall M, Weathers RE, et al. Infertility, infertility treatment, and achievement of pregnancy in female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol. 2013;14:873–81.

    Article  Google Scholar 

  12. Voigt PE, Blakemore JK, McCulloh DH, Fino ME. Equal opportunity for all? An analysis of race and ethnicity in fertility preservation (FP) in a major American city. Fertil Steril. 2019;112:e139–40.

    Article  Google Scholar 

  13. Groves RM, Mosher WD, Lepkowski JM, Kirgis NG. Planning and development of the continuous National Survey of Family Growth. Vital Health Stat. 2009;1:1–64.

    Google Scholar 

  14. Bureau USC. QuickFacts. In, 2019.

  15. Chandra A, Copen CE, Stephen EH. Infertility service use in the United States: data from the National Survey of Family Growth, 1982–2010. Natl Health Stat Report 2014:1–21.

  16. Bitler M, Schmidt L. Health disparities and infertility: impacts of state-level insurance mandates. Fertil Steril. 2006;85:858–65.

    Article  Google Scholar 

  17. Missmer SA, Seifer DB, Jain T. Cultural factors contributing to health care disparities among patients with infertility in Midwestern United States. Fertil Steril. 2011;95:1943–9.

    Article  Google Scholar 

  18. Letourneau JM, Smith JF, Ebbel EE, Craig A, Katz PP, Cedars MI, et al. Racial, socioeconomic, and demographic disparities in access to fertility preservation in young women diagnosed with cancer. Cancer. 2012;118:4579–88.

    Article  Google Scholar 

  19. Letourneau JM, Smith JF, Ebbel EE, Craig A, Katz PP, Cedars MI, et al. Racial, socioeconomic, and demographic disparities in access to fertility preservation in young women diagnosed with cancer. Cancer. 2012;118:4579–88.

    Article  Google Scholar 

  20. Flink DM, Sheeder J, Kondapalli LA. Do Patient characteristics decide if young adult cancer patients undergo fertility preservation? J Adolesc Young Adult Oncol. 2017;6:223–8.

    Article  Google Scholar 

  21. Weigel G, Ranji U, Long M, Salganicoff A. Coverage and use of fertility services in the US. In: KFF. 2020. Retrieved from:

  22. Financing UDoHDoMaH. Utah 1115 Primary Care Network Demonstration Waiver. 2021. Retrieved from:

  23. Medicine TECotASfR. Disparities in access to effective treatment for infertility in the United State: an Ethics Committee opinion. Fertility and Sterility. 2021;116(1).

  24. Quinn GP, Vadaparampil ST, McGowan Lowrey K, Eidson S, Knapp C, Bukulmez O. State laws and regulations addressing third-party reimbursement for infertility treatment: implications for cancer survivors. Fertil Steril. 2011;95:72–8.

    Article  Google Scholar 

  25. Ashing-Giwa KT, Gonzalez P, Lim JW, Chung C, Paz B, Somlo G, et al. Diagnostic and therapeutic delays among a multiethnic sample of breast and cervical cancer survivors. Cancer. 2010;116:3195–204.

    Article  Google Scholar 

  26. Knopman JM, Papadopoulos EB, Grifo JA, Fino ME, Noyes N. Surviving childhood and reproductive-age malignancy: effects on fertility and future parenthood. Lancet Oncol. 2010;11:490–8.

    Article  Google Scholar 

  27. Goodman LR, Balthazar U, Kim J, Mersereau JE. Trends of socioeconomic disparities in referral patterns for fertility preservation consultation. Human reproduction (Oxford, England). 2012;27:2076–81.

    Article  Google Scholar 

  28. Voigt PE, Blakemore JK, McCulloh D, Fino ME. Equal opportunity for all? An analysis of race and ethnicity in fertility preservation in New York City. J Assist Reprod Genet. 2020. p. 1–8.

  29. White L, McQuillan J, Greil AL. Explaining disparities in treatment seeking: the case of infertility. Fertil Steril. 2006;85:853–7.

    Article  Google Scholar 

  30. Lawson AK, McGuire JM, Noncent E, Olivieri JF Jr, Smith KN, Marsh EE. Disparities in counseling female cancer patients for fertility preservation. J Womens Health (Larchmt). 2017;26:886–91.

    Article  Google Scholar 

  31. Bell AV. Beyond (financial) accessibility: inequalities within the medicalisation of infertility. Sociol Health Illn. 2010;32:631–46.

    Article  Google Scholar 

  32. Humphries LA, Chang O, Humm K, Sakkas D, Hacker MR. Influence of race and ethnicity on in vitro fertilization outcomes: systematic review. Am J Obstet Gynecol 2016;214:212.e1-.e17.

  33. Mathews TJ, Hamilton BE. Mean age of mothers is on the rise: United States, 2000–2014. In: National Center for Health Statistics. 2016. Retrieved from:

  34. Busnelli A, Vitagliano A, Mensi L, Acerboni S, Bulfoni A, Filippi F, et al. Fertility in female cancer survivors: a systematic review and meta-analysis. Reprod Biomed Online. 2020;41:96–112.

    Article  Google Scholar 

  35. Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006;24:2917–31.

    Article  Google Scholar 

Download references


The authors gratefully acknowledge the patients who completed the National Survey of Family Growth.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Paxton Voigt.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Voigt, P., Persily, J., Blakemore, J.K. et al. Sociodemographic differences in utilization of fertility services among reproductive age women diagnosed with cancer in the USA. J Assist Reprod Genet 39, 963–972 (2022).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: